Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification

BACKGROUND: Flow diverters offer a promising treatment for cerebral aneurysms. However, they have associated thromboembolic risks, mandating chronic dual antiplatelet therapy (DAPT). Shield Technology is a phosphorylcholine surface modification of the Pipeline Embolization Device (PED) flow diverter...

Full description

Saved in:
Bibliographic Details
Published in:J Neurointerv Surg
Main Authors: Hagen, Matthew W, Girdhar, Gaurav, Wainwright, John, Hinds, Monica T
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2017
Subjects:
Basic Science
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5629931/
https://ncbi.nlm.nih.gov/pubmed/27799376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/neurintsurg-2016-012612
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items